Product Update
-
ENTOD Pharma introduces CYCLOTEARS eye drops
The first dry eye therapy to use the self-emulsifying drug delivery system technology ENTOD Pharmaceuticals has launched CYCLOTEARS eye drops…
Read More » -
Honeywell launches blue Spectra medical-grade bio fibre
The device is designed to improve visual contrast within critical surgical procedures Honeywell announced the expansion of its Spectra Medical…
Read More » -
Adroit Biomed launches immunity-enhancing tablets Glutone MD
Glutone MD provides potent antioxidant activity, liver protection, immune-boosting, anti-inflammatory and reducing muscle fatigue Mumbai-based Adroit Biomed has launched…
Read More » -
Axio Biosolutions receives European CE Mark approval
The company’s advanced woundcare product – MaxioCel; sets eye on Europe and other international markets Funded by Ratan Tata’s UC…
Read More » -
GSK Consumer Healthcare launches Otrivin Breathe Clean
The product comes in in a contemporary aerosol spray format, providing a great user experience GSK Consumer Healthcare announced the…
Read More » -
Cipla partners with Premier Medical Corporation
Launches ‘CIPtest’ rapid antigen detection test for COVID-19 diagnosis Cipla has partnered with Premier Medical Corporation for commercialisation of the…
Read More » -
DermaAngel forays into the Indian market
Launches two variants of acne patch BenQ Materials Corp has forayed into the Indian market with the launch of acne…
Read More » -
Co-Diagnostics JV Receives Indian Regulatory Approval for Five Diagnostic Assays
Salt Lake City: Co-Diagnostics, Inc., Utah based molecular diagnostics company with a unique, patented platform for the development of molecular…
Read More » -
Now Cipla to sell Alvotech’s Adalimumab Biosimilar in Emerging Markets
Biopharmaceutical company Alvotech and Cipla Gulf, a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited, today announced that…
Read More » -
Health Canada Approves Biocon & Mylan’s biosimilar Trastuzumab, Ogivri
Biocon Ltd. and Mylan N.V. today announced that Health Canada has approved Mylan’s Ogivri™(trastuzumab), a biosimilar to Herceptin ® 1…
Read More »
